Europe • Euronext Paris • EPA:ALSMA • FR0014005I80
The current stock price of ALSMA.PA is 6.8 EUR. In the past month the price increased by 6.25%. In the past year, price increased by 115.87%.
ChartMill assigns a technical rating of 9 / 10 to ALSMA.PA. When comparing the yearly performance of all stocks, ALSMA.PA is one of the better performing stocks in the market, outperforming 95.92% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to ALSMA.PA. The financial health of ALSMA.PA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months ALSMA.PA reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 36.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.39% | ||
| ROE | -25% | ||
| Debt/Equity | 0.33 |
10 analysts have analysed ALSMA.PA and the average price target is 8.26 EUR. This implies a price increase of 21.5% is expected in the next year compared to the current price of 6.8.
For the next year, analysts expect an EPS growth of 36.25% and a revenue growth 81.82% for ALSMA.PA
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.61 | 113.53B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.75 | 108.30B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.64 | 47.55B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.73 | 23.84B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.61 | 23.68B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.64 | 23.72B | ||
| BIM.PA | BIOMERIEUX | 25.22 | 11.52B | ||
| DIA.MI | DIASORIN SPA | 22.45 | 4.16B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 130.21 | 3.92B | ||
| 1AFX.MI | CARL ZEISS MEDITEC AG - BR | 17.45 | 2.51B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 17.12 | 2.46B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 13.75 | 1.66B |
S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes and currently employs 43 full-time employees. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.
SMAIO SA
2 Place Berthe Morisot, Parc Technologique
Saint-Priest AUVERGNE-RHONE-ALPES FR
Employees: 41
Phone: 33469842302
S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes and currently employs 43 full-time employees. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.
The current stock price of ALSMA.PA is 6.8 EUR. The price increased by 0.74% in the last trading session.
ALSMA.PA does not pay a dividend.
ALSMA.PA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
SMAIO SA (ALSMA.PA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
SMAIO SA (ALSMA.PA) currently has 41 employees.
SMAIO SA (ALSMA.PA) has a market capitalization of 38.42M EUR. This makes ALSMA.PA a Nano Cap stock.